“Is sotagliflozin a ‘wonder drug’? A review of its impact on cardiovascular, diabetic, renal, neuroprotective, and hepatic outcomes”Eeshal Fatima, Aymar Akilimali, Hamza Irfan et al.|Annals of Medicine and Surgery|2025Cited by 4
BMI, Central Adiposity, Hypertension, Obesity, Overweight.Jyoti Jain, Rahul Chanchlani, Kanika Agarwal et al.|Unknown|2014Cited by 0